Truveris is a technology company driving transparency, access and lower costs across the prescription drug ecosystem.
Truveris has raised $15.0M in total funding. The most recent round was Series E. The last funding was announced in May 2024.
Truveris's investors include First Round Capital, Tribeca Venture Partners, PROOF, Canaan Partners, New Leaf Venture Partners.
Truveris is headquartered in New York, United States.
Truveris is a technology company driving transparency, access and lower costs across the prescription drug ecosystem.
Truveris is at the Series E stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Truveris — Funding & Investors." VCBacked, May 14, 2024, https://www.vcbacked.co/company/truveris. Accessed July 19, 2026.
VCBacked. (2024). Truveris — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/truveris
{{cite web |title=Truveris — Funding & Investors |url=https://www.vcbacked.co/company/truveris |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated